Form 4: TriSalus Life Sciences Executive Receives Stock Options and Restricted Stock Units

Richard Marshak, a Senior Vice President at TriSalus Life Sciences, was granted stock options and restricted stock units as part of his compensation.

Summary

• Richard Marshak, Senior Vice President of Corporate Development & Strategy at TriSalus Life Sciences, received 6,875 restricted stock units and options to purchase 41,250 shares of common stock on November 14, 2024.
• The restricted stock units vest in four equal annual installments starting November 14, 2024, contingent on continued service.
• The stock options vest with one-fourth vesting after one year from November 14, 2024, and the remaining shares vesting monthly over the following three years, also contingent on continued service.

Sentiment

Score: 7

Explanation: The document reflects a standard compensation practice, which is generally positive for aligning management with shareholder interests. There are no indications of negative sentiment.

Positives

• The grants of stock options and restricted stock units align the executive's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the executive.

Risks

• The value of the stock options and restricted stock units is dependent on the future performance of TriSalus Life Sciences.
• The executive must remain employed by the company to fully vest in the awards.

Future Outlook

The vesting of the stock options and restricted stock units is contingent on the executive's continued service with the company.

Industry Context

The granting of stock options and restricted stock units is a common practice in the biotechnology industry to attract and retain key talent.

Comparison to Industry Standards

• Stock option and RSU grants are standard practice for executive compensation in the biotech industry, often used to align management interests with shareholder value creation.
• Vesting schedules of four years with a one-year cliff are common, similar to those used by companies like Amgen and Gilead Sciences.
• The specific number of shares and option prices are company-specific and depend on the company's valuation and compensation strategy.

Stakeholder Impact

• The stock options and restricted stock units may incentivize the executive to work towards increasing shareholder value.
• The vesting schedule encourages long-term commitment from the executive, which can benefit the company and its stakeholders.

Key Dates

Keywords

stock options, restricted stock units, equity compensation, TriSalus Life Sciences, executive compensation, insider trading, form 4